Showing 111-120 of 4704 results for "".
The Landscape of Vitiligo Treatment
https://practicaldermatology.com/series/updates-vitiligo/the-landscape-of-vitiligo-treatment/24467/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, talks with Lawrence Green, MD, a dermatologist practicing in Rockville, MD, about the landscape of treatments for patients with vitiligo and new therapies that may be coming from ongoing clinical trials.Calling Out Hesitation on Systemics
https://reachmd.com/programs/practical-dermatology/calling-out-hesitation-on-systemics/35703/The latest news and updates, plus Jason E. Hawkes, MD, MS, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss why dermatologists should not be reluctant to prescribe systemic therapies, and Linda F. Stein Gold, MD, discusses the importance of an ever-expanding aWinning Combinations in Cosmetic Dermatology
https://practicaldermatology.com/conferences/maui-derm-2022/winning-combinations-in-cosmetic-dermatology/20280/When it comes to ensuring the best results possible for aesthetic treatments, Suneel Chilukuri, MD says combinations are key. He discusses his approach for patients using neurotoxins, fillers, and devices.Hot Topics: Does Looking Natural Matter?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/hot-topics-does-looking-natural-matter/18206/What is a natural result? It's the number one concern patients have when they come into the office. Steven Dayan, MD and Joel L. Cohen, MD discuss the aim of cosmetic interventions.Scientifically Speaking: Effective By Design with Josh Makower, MD
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-effective-by-design-with-josh-makower-md/20106/Josh Makower, MD has been at the forefront of several medical innovations. Listen in as he describes his approach and discusses his latest product with host Joel L. Cohen, MD. The Avéli device from Revelle Aesthetics is FDA-cleared to reduce cellulite in the buttocks and thighs temporarily.Cosmetics Challenge
https://practicaldermatology.com/topics/general-topics/cosmetics-challenge/21793/Physician Spotlight: Jody Comstock, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-jody-comstock-md-phd/20525/Exploring the role of physician assistants in cosmetic dermatology.DermWireTV: Cosmetic Surgery Forum Highlights, LEO Focuses on AD
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-cosmetic-surgery-forum-highlights-leo-focuses-on-ad/19703/New treatments and medical controversies take center stage at Cosmetic Surgery Forum as the meeting moves to Nashville in its 11th Year. Leo Pharma’s tralokinumab meets all primary and secondary endpoints in three pivotal Phase 3 studies for the treatment of adults with moderate-to-severe atopic derCurrents: Cosmetic Dermatology Updates
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/currents-cosmetic-dermatology-updates/23848/Journal Club: Treating Itch and Lessons from the IL-4 and IL-13 Blockade
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-treating-itch-and-lessons-from-the-il-4-and-il-13-blockade/27025/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, chats with dermatologist Matthew Zirwas, MD, about how evaluations of itch can lead to treatment for atopic dermatitis, and his Journal of Drugs in Dermatology article "Unexpected Clinical Lessons Learned From IL-4 and IL-13 Blockade."